A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Orthofix Medical Inc.
OFIX
$445M
Mkt Cap
$11.25
+2.65%
Orthofix Medical Inc. (OFIX) has a 5-year average return on invested capital (ROIC) of -14.1%. This is below average and may indicate limited pricing power.
Orthofix Medical Inc. (OFIX) has a market capitalization of $454M. It is classified as a small-cap stock.
Orthofix Medical Inc. (OFIX) does not currently pay a regular dividend.
Orthofix Medical Inc. (OFIX) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
Orthofix Medical Inc. (OFIX) reported annual revenue of $822 million in its most recent fiscal year, based on SEC EDGAR filings.
Orthofix Medical Inc. (OFIX) has a net profit margin of -11.2%. The company is currently unprofitable.
Orthofix Medical Inc. (OFIX) generated $-1 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
In this Annual Report, the terms "we," "us," "our," "Orthofix," and "the Company" refer to the combined operations of Orthofix Medical Inc. and its consolidated subsidiaries and affiliates, unless the context requires otherwise. Company Overview Orthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. The Company was founded in Verona, Italy in 1980 and formally incorporated in 1987 in Curaçao as "Orthofix International N.V." In 2018, we completed a change in our jurisdiction of organization from Curaçao to the State of Delaware and changed our name to "Orthofix Medical Inc.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 825M | 822M | 799M | 747M | 461M | 464M |
| Net Income | -60M | -92M | -126M | -151M | -20M | -38M |
| EPS | $-1.51 | $-2.33 | $-3.30 | $-4.12 | $-0.49 | $-0.98 |
| Free Cash Flow | -4.4M | -1.3M | -9.1M | -106M | -33M | 690K |
| ROIC | -6.9% | -14.5% | -18.6% | -28.9% | -5.5% | -3.0% |
| Gross Margin | 70.7% | 68.8% | 68.3% | 65.1% | 73.2% | 75.3% |
| Debt/Equity | 0.51 | 0.41 | 0.60 | 0.19 | 0.08 | 0.08 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -47M | -81M | -85M | -139M | -13M | -8.3M |
| Operating Margin | -5.7% | -9.9% | -10.6% | -18.6% | -2.9% | -1.8% |
| ROE | -13.8% | -19.3% | -22.9% | -32.4% | -5.9% | -11.1% |
| Shares Outstanding | 40M | 40M | 38M | 37M | 40M | 39M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 402M | 396M | 410M | 434M | 453M | 460M | 407M | 464M | 461M | 747M | 799M | 822M | 825M |
| Gross Margin | 75.4% | 78.2% | 78.6% | 78.6% | 78.7% | 78.1% | 74.9% | 75.3% | 73.2% | 65.1% | 68.3% | 68.8% | 70.7% |
| R&D | 25M | 26M | 29M | 30M | 33M | 35M | 39M | 50M | 49M | 80M | 74M | 66M | 61M |
| SG&A | 79M | 87M | 76M | 72M | 83M | 86M | 68M | 69M | 309M | 530M | 533M | 554M | 556M |
| EBIT | 17M | 9.3M | 21M | 41M | 30M | -19M | -6.3M | -8.3M | -13M | -139M | -85M | -81M | -47M |
| Op. Margin | 4.3% | 2.3% | 5.1% | 9.4% | 6.6% | -4.1% | -1.5% | -1.8% | -2.9% | -18.6% | -10.6% | -9.9% | -5.7% |
| Net Income | -8.5M | -2.8M | 3.1M | 6.2M | 14M | -28M | 2.5M | -38M | -20M | -151M | -126M | -92M | -60M |
| Net Margin | -2.1% | -0.7% | 0.7% | 1.4% | 3.0% | -6.2% | 0.6% | -8.3% | -4.3% | -20.3% | -15.8% | -11.2% | -7.3% |
| Non-Recurring | 0 | 3.1M | 2.4M | 0 | 0 | 0 | 0 | 12M | -1.9M | -724K | 7.4M | -1.1M | -1.1M |
| Returns on Capital | |||||||||||||
| ROIC | 4.6% | 2.5% | 5.5% | 10.8% | 7.4% | -8.3% | 0.7% | -3.0% | -5.5% | -28.9% | -18.6% | -14.5% | -6.9% |
| ROE | -2.9% | -1.0% | 1.1% | 2.2% | 4.4% | -8.6% | 0.7% | -11.1% | -5.9% | -32.4% | -22.9% | -19.3% | -13.8% |
| ROA | -2.1% | -0.7% | 0.8% | 1.6% | 3.2% | -5.9% | 0.5% | -7.7% | -4.2% | -21.9% | -13.9% | -10.6% | -6.8% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 51M | 44M | 59M | 39M | 50M | 32M | 74M | 18M | -12M | -46M | 26M | 33M | 34M |
| Free Cash Flow | 33M | 16M | 43M | 24M | 36M | 13M | 59M | 690K | -33M | -106M | -9.1M | -1.3M | -4.4M |
| Owner Earnings | 23M | 15M | 22M | 6.3M | 12M | -14M | 28M | -27M | -59M | -135M | -67M | -73M | -51M |
| CapEx | 18M | 27M | 16M | 15M | 14M | 19M | 15M | 18M | 21M | 60M | 35M | 35M | 39M |
| Maint. CapEx | 23M | 21M | 21M | 20M | 19M | 25M | 31M | 30M | 29M | 53M | 60M | 77M | 56M |
| Growth CapEx | 0 | 6.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.2M | 0 | 0 | 0 |
| D&A | 23M | 21M | 21M | 20M | 19M | 25M | 31M | 30M | 29M | 53M | 60M | 77M | 56M |
| CapEx/OCF | 35.3% | 62.4% | 27.8% | 37.6% | 27.2% | 59.3% | 20.8% | 96.3% | N/A | N/A | 135.2% | 103.8% | 113.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 12M | 63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | 1.6% | 9.9% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 5.7M | 7.2M | 16M | 13M | 19M | 22M | 16M | 15M | 18M | 36M | 32M | 29M | 29M |
| Debt Repayment | 0 | 1.8M | 0 | 445K | 682K | 3.0M | 1.5M | 948K | 92K | 2.4M | 3.6M | 531K | 531K |
| Balance Sheet | |||||||||||||
| Net Debt | -88M | -57M | -33M | -74M | N/A | -43M | -78M | -64M | -24M | 82M | 217M | 104M | 101M |
| Cash & Equiv. | 37M | 64M | 40M | 81M | 70M | 70M | 96M | 88M | 51M | 33M | 83M | 82M | 120M |
| Long-Term Debt | 0 | N/A | N/A | N/A | N/A | 21M | 22M | 20M | 19M | 93M | 157M | 157M | 221M |
| Debt/Equity | 0.07 | 0.02 | 0.02 | 0.02 | 0.39 | 0.08 | 0.08 | 0.08 | 0.08 | 0.19 | 0.60 | 0.41 | 0.51 |
| Interest Coverage | 9.6 | 46.3 | 10.0 | 17.7 | 21.5 | -20.4 | -6.7 | -8.9 | -14.9 | -16.1 | -2.9 | -4.7 | -4.7 |
| Equity | 300M | 290M | 263M | 297M | 335M | 328M | 357M | 337M | 337M | 599M | 503M | 450M | 435M |
| Total Assets | 393M | 400M | 372M | 405M | 467M | 496M | 526M | 477M | 459M | 925M | 893M | 851M | 887M |
| Total Liabilities | 93M | 110M | 109M | 109M | 131M | 168M | 169M | 140M | 122M | 327M | 390M | 401M | 451M |
| Intangibles | 7.2M | 5.3M | 7.5M | 10M | 52M | 54M | 61M | 53M | 47M | 117M | 99M | 73M | 69M |
| Retained Earnings | 65M | 63M | 64M | 70M | 87M | 58M | 59M | 21M | 1.3M | -150M | -276M | -368M | -389M |
| Working Capital | 153M | 130M | 111M | 172M | 159M | 176M | 166M | 164M | 172M | 255M | 265M | 246M | 300M |
| Current Assets | 219M | 212M | 194M | 252M | 245M | 261M | 270M | 270M | 256M | 420M | 433M | 417M | 462M |
| Current Liabilities | 66M | 82M | 83M | 79M | 86M | 85M | 104M | 106M | 84M | 165M | 169M | 170M | 161M |
| Per Share Data | |||||||||||||
| EPS | -0.23 | -0.08 | 0.09 | 0.17 | 0.36 | -0.76 | 0.07 | -0.98 | -0.49 | -4.12 | -3.30 | -2.33 | -1.51 |
| Owner EPS | 0.61 | 0.41 | 0.62 | 0.17 | 0.32 | -0.38 | 0.71 | -0.67 | -1.46 | -3.66 | -1.75 | -1.84 | -1.26 |
| Book Value | 8.07 | 7.75 | 7.33 | 8.10 | 8.74 | 8.69 | 9.22 | 8.56 | 8.36 | 16.29 | 13.18 | 11.37 | 10.78 |
| Cash Flow/Share | 1.38 | 1.16 | 1.64 | 1.06 | 1.30 | 0.85 | 1.92 | 0.47 | -0.29 | -1.25 | 0.68 | 0.84 | -0.09 |
| Dividends/Share | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 37.1M | 37.5M | 36.0M | 36.6M | 38.4M | 37.7M | 38.7M | 39.4M | 40.3M | 36.7M | 38.2M | 39.6M | 40.4M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | 210.1 | 162.3 | 73.0 | N/A | 331.8 | N/A | N/A | N/A | N/A | N/A | -7.5 |
| P/FCF | 34.5 | 89.5 | 30.1 | 83.1 | 55.5 | 133.1 | 28.4 | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | 28.2 | 73.1 | 28.9 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 1.9 | 2.5 | 2.4 | 3.4 | 3.0 | 2.6 | 2.3 | 1.8 | 1.2 | 0.9 | 1.3 | 1.3 | 1.0 |
| Price/Sales | 1.4 | 1.6 | 1.8 | 1.9 | 2.4 | 2.1 | 1.7 | 1.7 | 1.1 | 0.8 | 0.7 | 0.7 | 0.6 |
| FCF Yield | 5.8% | 2.2% | 6.6% | 2.4% | 3.6% | 1.5% | 7.0% | 0.1% | -8.5% | -20.8% | -1.4% | -0.2% | -1.0% |
| Market Cap | 571M | 734M | 642M | 1.0B | 1.0B | 867M | 835M | 618M | 388M | 510M | 669M | 603M | 454M |
| Avg. Price | 29.47 | 34.62 | 41.37 | 44.25 | 56.48 | 51.97 | 34.82 | 39.99 | 25.31 | 17.03 | 15.23 | 14.57 | 11.25 |
| Year-End Price | 30.78 | 39.21 | 35.71 | 55.19 | 52.53 | 46.02 | 43.13 | 31.42 | 19.25 | 13.87 | 17.53 | 15.24 | 11.25 |
Orthofix Medical Inc. passes 3 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 70.1%. At current prices, the estimated annualized return to fair value is -18.9%.
Orthofix Medical Inc. (OFIX) has a debt-to-equity ratio of 0.41. This indicates a conservatively financed balance sheet.
Orthofix Medical Inc. (OFIX) reported earnings per share (EPS) of $-2.33 in its most recent fiscal year.
Orthofix Medical Inc. (OFIX) has a return on equity (ROE) of -19.3%. A negative ROE may indicate losses or negative equity.
Orthofix Medical Inc. (OFIX) has a 5-year average gross margin of 70.1%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 17 years of financial data for Orthofix Medical Inc. (OFIX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Orthofix Medical Inc. (OFIX) has a book value per share of $11.37, based on its most recent annual SEC filing.